These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 7542520

  • 1. Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems.
    Corell T, Pedersen SB, Lissau B, Moilanen E, Metsä-Ketelä T, Kankaanranta H, Vuorinen P, Vapaatalo H, Rydell E, Andersson R.
    Pol J Pharmacol; 1994; 46(6):553-66. PubMed ID: 7542520
    [Abstract] [Full Text] [Related]

  • 2. Mesoionic oxatriazole derivatives--a new group of NO-donors.
    Karup G, Preikschat H, Wilhelmsen ES, Pedersen SB, Marcinkiewicz E, Cieślik K, Gryglewski RJ.
    Pol J Pharmacol; 1994; 46(6):541-52. PubMed ID: 7620516
    [Abstract] [Full Text] [Related]

  • 3. Cross-talk between adenosine and the oxatriazole derivative GEA 3175 in platelets.
    Asplund Persson A, Zalavary S, Lindström E, Whiss PA, Bengtsson T, Grenegård M.
    Eur J Pharmacol; 2005 Jul 11; 517(3):149-57. PubMed ID: 15963495
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effects of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives on vascular smooth muscle cell mitogenesis and proliferation in vitro.
    Lähteenmäki T, Sievi E, Vapaatalo H.
    Br J Pharmacol; 1998 Sep 11; 125(2):402-8. PubMed ID: 9786515
    [Abstract] [Full Text] [Related]

  • 5. Potential protective properties of a stable, slow-releasing nitric oxide donor, GEA 3175, in the lung.
    Laursen BE, Stankevicius E, Pilegaard H, Mulvany M, Simonsen U.
    Cardiovasc Drug Rev; 2006 Sep 11; 24(3-4):247-60. PubMed ID: 17214601
    [Abstract] [Full Text] [Related]

  • 6. Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives.
    Kankaanranta H, Rydell E, Petersson AS, Holm P, Moilanen E, Corell T, Karup G, Vuorinen P, Pedersen SB, Wennmalm A, Metsä-Ketelä T.
    Br J Pharmacol; 1996 Feb 11; 117(3):401-406. PubMed ID: 8821526
    [Abstract] [Full Text] [Related]

  • 7. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
    Hwang TL, Wu CC, Teng CM.
    Br J Pharmacol; 1998 Nov 11; 125(6):1158-63. PubMed ID: 9863642
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
    Severina IS, Belushkina NN, Grigoryev NB.
    Biochem Mol Biol Int; 1994 Aug 11; 33(5):957-67. PubMed ID: 7987264
    [Abstract] [Full Text] [Related]

  • 9. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
    Gordge MP, Hothersall JS, Noronha-Dutra AA.
    Br J Pharmacol; 1998 May 11; 124(1):141-8. PubMed ID: 9630353
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide as a regulator of prostacyclin synthesis in cultured rat heart endothelial cells.
    Sievi E, Lähteenmäki TA, Alanko J, Vuorinen P, Vapaatalo H.
    Arzneimittelforschung; 1997 Oct 11; 47(10):1093-8. PubMed ID: 9368700
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity.
    Fernandes D, da Silva-Santos JE, Duma D, Villela CG, Barja-Fidalgo C, Assreuy J.
    Mol Pharmacol; 2006 Mar 11; 69(3):983-90. PubMed ID: 16326931
    [Abstract] [Full Text] [Related]

  • 12. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
    Bussygina OG, Pyatakova NV, Khropov YV, Ovchinnikov IV, Makhova NN, Severina IS.
    Biochemistry (Mosc); 2000 Apr 11; 65(4):457-62. PubMed ID: 10810184
    [Abstract] [Full Text] [Related]

  • 13. Modulation of neuronal nitric oxide release by soluble guanylyl cyclase in guinea pig colon.
    Hallén K, Olgart C, Gustafsson LE, Wiklund NP.
    Biochem Biophys Res Commun; 2001 Feb 02; 280(4):1130-4. PubMed ID: 11162644
    [Abstract] [Full Text] [Related]

  • 14. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R.
    Cardiovasc Res; 2006 Jul 15; 71(2):393-401. PubMed ID: 16713591
    [Abstract] [Full Text] [Related]

  • 15. Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure.
    Kotikoski H, Kankuri E, Vapaatalo H.
    Med Sci Monit; 2003 Jan 15; 9(1):BR1-7. PubMed ID: 12552230
    [Abstract] [Full Text] [Related]

  • 16. Nitric oxide-releasing oxatriazole derivatives inhibit human lymphocyte proliferation by a cyclic GMP-independent mechanism.
    Kosonen O, Kankaanranta H, Lähde M, Vuorinen P, Ylitalo P, Moilanen E.
    J Pharmacol Exp Ther; 1998 Jul 15; 286(1):215-20. PubMed ID: 9655862
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and its metabolites.
    Nishikawa M, Kanamori M, Hidaka H.
    J Pharmacol Exp Ther; 1982 Jan 15; 220(1):183-90. PubMed ID: 6118429
    [No Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist.
    Hanson J, Rolin S, Reynaud D, Qiao N, Kelley LP, Reid HM, Valentin F, Tippins J, Kinsella BT, Masereel B, Pace-Asciak C, Pirotte B, Dogné JM.
    J Pharmacol Exp Ther; 2005 Apr 15; 313(1):293-301. PubMed ID: 15626721
    [Abstract] [Full Text] [Related]

  • 19. [Antiplatelet properties of nitrogen monoxide].
    Adrie C.
    Arch Mal Coeur Vaiss; 1996 Nov 15; 89(11 Suppl):1527-32. PubMed ID: 9092414
    [Abstract] [Full Text] [Related]

  • 20. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, Nielsen-Kudsk JE, Busse R, Mülsch A.
    Br J Pharmacol; 1998 Jan 15; 123(2):299-309. PubMed ID: 9489619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.